Alignment Healthcare, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -1.34%

Alignment Healthcare, Inc. EBITDA Margin is -1.34% for the Trailing 12 Months (TTM) ending March 31, 2025, a -76.13% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Alignment Healthcare, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -5.62%, a -20.91% change year over year.
  • Alignment Healthcare, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -7.10%, a -39.15% change year over year.
  • Alignment Healthcare, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -11.67%, a 221.80% change year over year.
  • Alignment Healthcare, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -3.63%.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin